Dr. Garry Tim Miller Ii, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 W Sr 164 North, Salem, UT 84653 Phone: 801-465-4813 Fax: 801-812-5433 |
Tala'at Al-shuqairat, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 W Sr 164, Salem, UT 84653 Phone: 801-465-4813 Fax: 801-812-5433 |
Dr. Troy Lunceford, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 W Sr 164, Salem, UT 84653 Phone: 801-465-4813 Fax: 801-812-5433 |
David F Bennion, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 West Sr 164 North, Salem, UT 84651 Phone: 801-465-4813 Fax: 801-812-5433 |
Brian A Clements, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 W Sr 164, Salem, UT 84653 Phone: 801-465-4813 Fax: 801-812-5433 |
Alan B Erdmann, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 555 W Sr 164, Salem, UT 84653 Phone: 801-374-1268 Fax: 801-812-5454 |
News Archive
The findings, which will be presented Tuesday, April 19, at the American Association for Cancer Research annual meeting, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.
Researchers at NYU Langone Medical Center today announce findings published in the October 20 issue of Nature that show for the first time the inhibition of both microRNA-33a and microRNA-33b (miR-33a/b) with chemically modified anti-miR oligonucleotides markedly suppress triglyceride levels and cause a sustained increase in high density lipoprotein cholesterol (HDL-C) "good" cholesterol.
People who have recovered from COVID-19, and their close contacts, could hold the key to understanding how immunity to the disease develops, how long it lasts and what happens when immunity is lost.
The Research Luxembourg COVID-19 task force announces the start of "Predi-COVID", a study that aims to identify important risk factors and biomarkers associated with COVID-19 severity and long-term health consequences of the disease in Luxembourg.
NHS Choices, the online 'front door' to the NHS, launches a daily health news service to help people make sense of the stories appearing in the news about medical research.
› Verified 4 days ago